National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting, 60614 [2017-27508]

Download as PDF 60614 Federal Register / Vol. 82, No. 244 / Thursday, December 21, 2017 / Notices that will be provided to OCSE in a state TANF agency input file are: • Submitting state code (2-digit FIPS code) • Date stamp (input file transmission date) • Adult TANF applicant/recipient’s Social Security number • Adult TANF applicant/recipient’s first, middle, and last name • Same state data indicator (indicates whether the state TANF agency requests NDNH new hire, quarterly wage, or unemployment insurance even if the information was provided by that same state) • Passback data (state TANF agency information used to identify individuals within the input file to be returned on the output file) • Name/Social Security number verification request OCSE will compare the Social Security numbers in the state TANF agency input file to the Social Security numbers in the NDNH, and will provide the state TANF agency with any available new hire and quarterly wage information in NDNH (including names, Social Security numbers, home addresses, and employment information) pertaining to the individuals whose records are contained in the state TANF agency input file. System(s) of Records: The OCSE records disclosed to state TANF agencies will be disclosed from OCSE’s National Directory of New Hires (NDNH) system of records, No. 09–80– 0381, last published at 80 FR 17906 on April 2, 2015. The disclosures are authorized by routine use 8 in that system of records. Scott M. Lekan, Commissioner, Office of Child Support Enforcement. property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR16–212: Cognitive Neuroscience and Assessment of Cancer Treatment-Related Cognitive Impairment. Date: January 17, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kristin Kramer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5205, MSC 7846, Bethesda, MD 20892, (301) 437– 0911, kramerkm@csr.nih.gov. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Psychosocial Risk and Disease Prevention Study Section. Date: January 22–23, 2018. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Stacey FitzSimmons, Ph.D., MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD 20892, (301) 451– 9956, fitzsimmonss@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: December 18, 2017. Melanie J. Pantoja, Program Analyst; Office of Federal Advisory Committee Policy. [FR Doc. 2017–27487 Filed 12–20–17; 8:45 am] BILLING CODE 4184–42–P [FR Doc. 2017–27506 Filed 12–20–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Center for Scientific Review; Notice of Closed Meetings daltland on DSKBBV9HB2PROD with NOTICES National Institutes of Health National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial VerDate Sep<11>2014 20:57 Dec 20, 2017 Jkt 244001 National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering. The meeting will be open to the public as indicated below, with PO 00000 Frm 00037 Fmt 4703 Sfmt 9990 attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering. Date: January 18, 2018. Open: 8:30 a.m. to 11:45 a.m. Agenda: Report from the Institute Director, other Institute Staff and scientific presentation. Place: The William F. Bolger Center, Franklin Building, Classroom 3, 9600 Newbridge Drive, Potomac, MD 20854. Closed: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: The William F. Bolger Center, Franklin Building, Classroom 3, 9600 Newbridge Drive, Potomac, MD 20854. Contact Person: David T. George, Ph.D., Acting Associate Director, Office of Research Administration, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Room 920, Bethesda, MD 20892. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nibib1.nih.gov/about/NACBIB/ NACBIB.htm, where an agenda and any additional information for the meeting will be posted when available. Dated: December 18, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–27508 Filed 12–20–17; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\21DEN1.SGM 21DEN1

Agencies

[Federal Register Volume 82, Number 244 (Thursday, December 21, 2017)]
[Notices]
[Page 60614]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27508]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Council for Biomedical Imaging and Bioengineering.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Biomedical 
Imaging and Bioengineering.
    Date: January 18, 2018.
    Open: 8:30 a.m. to 11:45 a.m.
    Agenda: Report from the Institute Director, other Institute 
Staff and scientific presentation.
    Place: The William F. Bolger Center, Franklin Building, 
Classroom 3, 9600 Newbridge Drive, Potomac, MD 20854.
    Closed: 1:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: The William F. Bolger Center, Franklin Building, 
Classroom 3, 9600 Newbridge Drive, Potomac, MD 20854.
    Contact Person: David T. George, Ph.D., Acting Associate 
Director, Office of Research Administration, National Institute of 
Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, 
Room 920, Bethesda, MD 20892.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.nibib1.nih.gov/about/NACBIB/NACBIB.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

    Dated: December 18, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-27508 Filed 12-20-17; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.